Correlation Between Ibio and Aridis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ibio and Aridis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ibio and Aridis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ibio Inc and Aridis Pharmaceuticals, you can compare the effects of market volatilities on Ibio and Aridis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ibio with a short position of Aridis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ibio and Aridis Pharmaceuticals.
Diversification Opportunities for Ibio and Aridis Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ibio and Aridis is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Ibio Inc and Aridis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aridis Pharmaceuticals and Ibio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ibio Inc are associated (or correlated) with Aridis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aridis Pharmaceuticals has no effect on the direction of Ibio i.e., Ibio and Aridis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ibio and Aridis Pharmaceuticals
Given the investment horizon of 90 days Ibio Inc is expected to under-perform the Aridis Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Ibio Inc is 1.51 times less risky than Aridis Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Aridis Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 18.00 in Aridis Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 9.00 from holding Aridis Pharmaceuticals or generate 50.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 13.45% |
| Values | Daily Returns |
Ibio Inc vs. Aridis Pharmaceuticals
Performance |
| Timeline |
| Ibio Inc |
| Aridis Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Ibio and Aridis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ibio and Aridis Pharmaceuticals
The main advantage of trading using opposite Ibio and Aridis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ibio position performs unexpectedly, Aridis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aridis Pharmaceuticals will offset losses from the drop in Aridis Pharmaceuticals' long position.| Ibio vs. Jaguar Animal Health | Ibio vs. GeoVax Labs | Ibio vs. Ocugen Inc | Ibio vs. Tonix Pharmaceuticals Holding |
| Aridis Pharmaceuticals vs. Akari Therapeutics PLC | Aridis Pharmaceuticals vs. Aditxt Inc | Aridis Pharmaceuticals vs. ABVC Biopharma | Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |